1. Home
  2. NVCR vs HLIO Comparison

NVCR vs HLIO Comparison

Compare NVCR & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • HLIO
  • Stock Information
  • Founded
  • NVCR 2000
  • HLIO 1970
  • Country
  • NVCR Switzerland
  • HLIO United States
  • Employees
  • NVCR N/A
  • HLIO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • HLIO Metal Fabrications
  • Sector
  • NVCR Health Care
  • HLIO Industrials
  • Exchange
  • NVCR Nasdaq
  • HLIO Nasdaq
  • Market Cap
  • NVCR 1.4B
  • HLIO 1.2B
  • IPO Year
  • NVCR 2015
  • HLIO N/A
  • Fundamental
  • Price
  • NVCR $11.32
  • HLIO $35.41
  • Analyst Decision
  • NVCR Buy
  • HLIO Strong Buy
  • Analyst Count
  • NVCR 7
  • HLIO 3
  • Target Price
  • NVCR $28.79
  • HLIO $44.00
  • AVG Volume (30 Days)
  • NVCR 1.7M
  • HLIO 356.1K
  • Earning Date
  • NVCR 07-24-2025
  • HLIO 08-04-2025
  • Dividend Yield
  • NVCR N/A
  • HLIO 1.02%
  • EPS Growth
  • NVCR N/A
  • HLIO 11.74
  • EPS
  • NVCR N/A
  • HLIO 1.11
  • Revenue
  • NVCR $630,160,000.00
  • HLIO $789,400,000.00
  • Revenue This Year
  • NVCR $6.15
  • HLIO N/A
  • Revenue Next Year
  • NVCR $7.35
  • HLIO $4.48
  • P/E Ratio
  • NVCR N/A
  • HLIO $31.88
  • Revenue Growth
  • NVCR 14.58
  • HLIO N/A
  • 52 Week Low
  • NVCR $10.91
  • HLIO $24.76
  • 52 Week High
  • NVCR $34.13
  • HLIO $57.29
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 25.05
  • HLIO 48.32
  • Support Level
  • NVCR $10.91
  • HLIO $35.56
  • Resistance Level
  • NVCR $12.38
  • HLIO $38.70
  • Average True Range (ATR)
  • NVCR 0.93
  • HLIO 1.27
  • MACD
  • NVCR -0.49
  • HLIO -0.21
  • Stochastic Oscillator
  • NVCR 6.13
  • HLIO 32.16

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About HLIO Helios Technologies Inc.

Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.

Share on Social Networks: